Armata Pharmaceuticals, Inc. (ARMP) stock
ARMPNYSEBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$3.87+0.15 (+4.03%)
Close on Nov 13, 2026Market cap $143.89MP/E –Yield –
Armata Pharmaceuticals operating margin
Operating margin is operating income as a percentage of revenue.
For fiscal 2014 it was -3449.9%, against -15288.9% the year before.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2014 | Dec 31, 2014 | -3449.9% | +11839.0 |
| FY2013 | Dec 31, 2013 | -15288.9% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2020 | Jun 30, 2020 | -14806.5% | – |
See a number that looks wrong?